Search
Rules:
Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.
Search for "therapy"
Displaying results 1 to 6 out of 6
 |
2000 – 2009 | 81% | |
| ... 30-Dezember 3, 2008 Baumann S . Sublingual immunotherapy (SLIT) adjuvanted with monophosphoryl lipid A (MPL®): ... of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res. 2008 Feb; ... S , Woroniecki SR, Klimek L. Sublingual immunotherapy adjuvanted with monophosphoryl lipid A: preliminary ... K , Burkhard-Meier C, Gülker H, Horlitz M. Curative | |||
| Size: 53 K - Created: 09-11-15 - Modified: 20-12-17 11:58 Path: /Expertise/Published Expertise/2000 – 2009 |
|||
|
Pharmacodynamic Expertise | 80% | |
| ... is the key benefit of biomarkers. Due to changes in biomarker patterns it is possible to distinguish between effective and ineffective drug therapy, which enables “go/no-go” decisions for the clinical drug development programmes of our clients combined with time and cost savings. CRS has ... | |||
| Size: 34 K - Created: 18-11-12 - Modified: 02-05-18 10:39 Path: /Expertise/Pharmacodynamic Expertise |
|||
|
Trial Expertise | 76% | |
| ... conducts various trials in this field to support the increase of beneficial effects and to enhance the prevention of negative effects from drug therapy. Because genetic factors affect human responses to therapeutic drugs, CRS has access to a broad range of genotyped subjects . Thorough ... | |||
| Size: 34 K - Created: 18-11-12 - Modified: 20-12-17 11:58 Path: /Expertise/Trial Expertise |
|||
|
1990 – 1999 | 75% | |
| ... activity of monophosphoryl lipid A in specific immunotherapy. J Clin Pharmacol 1999 ; 39(9):No. 47. Rensing UF, ... as a parameter of bioavailability of oral magnesium therapy. Methods Find Exp Clin Pharmacol. 1992 May; ... of Therpeutic Availability of Oral Magnesium Therapy. Poster, 13. Bobenheimer Allerheiligengespräch, ... R, editors. Pharmacological basis of cholinergic | |||
| Size: 61 K - Created: 18-11-12 - Modified: 20-12-17 11:58 Path: /Expertise/Published Expertise/1990 – 1999 |
|||
|
1981 – 1989 | 69% | |
| ... M, Zeidler H, König J, Kirch W. Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives. Cardiovascular Drugs and Therapy 1989 ; 3: 441-443. Halabi A , Zurborn KH, Kaiser P, Proppe D, Kirch W. Haemostaseological parameters and circadian blood pressure values in ... | |||
| Size: 41 K - Created: 18-11-12 - Modified: 20-12-17 11:58 Path: /Expertise/Published Expertise/1981 – 1989 |
|||
|
2010-2018 | 68% | |
| ... M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR The effects of weekly augmentation therapy in patients with PiZZ ?1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. ... Infusions in Healthy Volunteers - Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago, USAChemo | |||
| Size: 66 K - Created: 09-11-15 - Modified: 17-07-18 09:33 Path: /Expertise/Published Expertise/2010-2018 |
|||
